John L. Ziegler

11.6k total citations · 3 hit papers
140 papers, 7.8k citations indexed

About

John L. Ziegler is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, John L. Ziegler has authored 140 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 55 papers in Pathology and Forensic Medicine and 21 papers in Genetics. Recurrent topics in John L. Ziegler's work include Viral-associated cancers and disorders (54 papers), Lymphoma Diagnosis and Treatment (53 papers) and CNS Lymphoma Diagnosis and Treatment (17 papers). John L. Ziegler is often cited by papers focused on Viral-associated cancers and disorders (54 papers), Lymphoma Diagnosis and Treatment (53 papers) and CNS Lymphoma Diagnosis and Treatment (17 papers). John L. Ziegler collaborates with scholars based in United States, Uganda and United Kingdom. John L. Ziegler's co-authors include Ian Magrath, Richard H. Morrow, David G. Poplack, Sebastian K. Kyalwazi, Avrum Z. Bluming, Edward Katongole‐Mbidde, Robert Newton, Charles L. Vogel, Werner Henle and Charles L. M. Olweny and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John L. Ziegler

138 papers receiving 7.0k citations

Hit Papers

Spirochetes Isolated from... 1969 2026 1988 2007 1983 1996 1969 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John L. Ziegler United States 49 3.7k 2.4k 1.6k 1.5k 955 140 7.8k
Alvin E. Friedman‐Kien United States 44 3.6k 1.0× 1.5k 0.6× 1.9k 1.2× 3.2k 2.1× 295 0.3× 146 8.1k
David T. Purtilo United States 44 3.4k 0.9× 2.0k 0.8× 1.4k 0.9× 1.5k 0.9× 237 0.2× 173 6.4k
Philip E. LeBoit United States 55 6.0k 1.6× 1.8k 0.8× 862 0.6× 2.0k 1.3× 257 0.3× 219 12.2k
Annika Linde Sweden 44 2.1k 0.6× 612 0.3× 1.6k 1.0× 3.7k 2.4× 314 0.3× 198 6.4k
Robert J. Biggar United States 63 5.2k 1.4× 2.4k 1.0× 4.0k 2.6× 4.9k 3.2× 721 0.8× 237 13.0k
Rosemary Rochford United States 41 2.3k 0.6× 1.2k 0.5× 882 0.6× 2.0k 1.3× 830 0.9× 141 5.9k
E. Donnall Thomas United States 57 3.7k 1.0× 586 0.2× 666 0.4× 2.6k 1.7× 1.6k 1.7× 229 15.1k
Mark E. Nesbit United States 58 2.3k 0.6× 1.0k 0.4× 1.0k 0.7× 561 0.4× 2.7k 2.8× 188 10.6k
Keith M. Sullivan United States 66 3.9k 1.1× 1.6k 0.7× 747 0.5× 1.9k 1.2× 2.7k 2.9× 241 16.5k
E. Donnall Thomas United States 58 3.9k 1.1× 693 0.3× 650 0.4× 2.8k 1.8× 2.2k 2.3× 133 15.9k

Countries citing papers authored by John L. Ziegler

Since Specialization
Citations

This map shows the geographic impact of John L. Ziegler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Ziegler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Ziegler more than expected).

Fields of papers citing papers by John L. Ziegler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Ziegler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Ziegler. The network helps show where John L. Ziegler may publish in the future.

Co-authorship network of co-authors of John L. Ziegler

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Ziegler. A scholar is included among the top collaborators of John L. Ziegler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Ziegler. John L. Ziegler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ziegler, John L.. (2015). AIDS and Oncogenesis. Frontiers of radiation therapy and oncology. 19. 99–104.
2.
Ziegler, John L., et al.. (2013). Paediatric HIV in Australia: 30 years of a changing landscape. 11(1). 25. 3 indexed citations
3.
Beattie, Mary, et al.. (2009). Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers. Genetic Testing and Molecular Biomarkers. 13(1). 51–56. 79 indexed citations
4.
Ziegler, John L.. (2008). Hyper-reactive Malarial Splenomegaly. American Journal of Tropical Medicine and Hygiene. 78(2). 186–187. 6 indexed citations
5.
Komaromy, Miriam, et al.. (2007). Development and Pilot Evaluation of Novel Genetic Educational Materials Designed for an Underserved Patient Population. Genetic Testing. 11(3). 276–290. 22 indexed citations
6.
Carpenter, Lucy, Robert Newton, Delphine Casabonne, et al.. (2007). Antibodies against malaria and Epstein‐Barr virus in childhood Burkitt lymphoma: A case‐control study in Uganda. International Journal of Cancer. 122(6). 1319–1323. 75 indexed citations
7.
Newton, Robert, John L. Ziegler, Delphine Casabonne, et al.. (2007). A case–control study of cancer of the uterine cervix in Uganda. European Journal of Cancer Prevention. 16(6). 555–558. 5 indexed citations
8.
Chen, Ying, Amanda E. Toland, Jane McLennan, et al.. (2006). Lack of Germ-Line Promoter Methylation in BRCA1 -Negative Families with Familial Breast Cancer. Genetic Testing. 10(4). 281–284. 19 indexed citations
9.
Lee, Robin, Mary Beattie, Julie Mak, et al.. (2005). Recruitment, Genetic Counseling, and BRCA Testing for Underserved Women at a Public Hospital. Genetic Testing. 9(4). 306–312. 32 indexed citations
10.
Newton, Robert, John L. Ziegler, Dimitra Bourboulia, et al.. (2003). Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. British Journal of Cancer. 89(3). 502–504. 25 indexed citations
11.
Newton, Robert, John L. Ziegler, Valerie Beral, et al.. (2001). A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. International Journal of Cancer. 92(5). 622–627. 103 indexed citations
12.
Parkin, Donald Maxwell, et al.. (2000). Non-Hodgkin lymphoma in Uganda: a case–control study. AIDS. 14(18). 2929–2936. 68 indexed citations
13.
Gao, Shou‐Jiang, Lawrence Kingsley, Ming O. Li, et al.. (1996). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Medicine. 2(8). 925–928. 636 indexed citations breakdown →
14.
Ziegler, John L.. (1977). National Institutes of Health International Workshop on Hepatitis B and Liver Cancer. Cancer Research. 37(12). 4672–4672. 2 indexed citations
15.
Magrath, Ian & John L. Ziegler. (1976). Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.. BMJ. 1(6010). 615–618. 26 indexed citations
16.
Morrow, Richard H., et al.. (1971). Burkitt's Lymphoma: A Time-space Cluster of Cases in Bwanba County of Uganda. BMJ. 2(5760). 491–492. 31 indexed citations
17.
Ziegler, John L. & Avrum Z. Bluming. (1971). Intrathecal Chemotherapy in Burkitt's Lymphoma. BMJ. 3(5773). 508–512. 46 indexed citations
18.
Stuiver, P. C., et al.. (1971). Clinical Trial of Malaria Prophylaxis in Tropical Splenomegaly Syndrome. BMJ. 1(5746). 426–429. 27 indexed citations
19.
Kyalwazi, Sebastian K., et al.. (1970). Immunological Studies in Kaposi's Sarcoma in Uganda. BMJ. 1(5696). 600–602. 79 indexed citations
20.
Fass, Leroy, Ronald B. Herberman, John L. Ziegler, & Richard H. Morrow. (1970). Evaluation of the Effect of Remission Plasma on Untreated Patients With Burkitt's Lymphoma<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 44(1). 145–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026